2024-10-30 18:35:00
The annual epidemic of bronchiolitis, a dangerous disease for children, has begun, Public Health France reported on Wednesday, October 30. Last week was marked by “transition of Ile-de-France, Guadeloupe and Martinique into epidemic and Brittany into pre-epidemic”summarizes the health agency in a weekly report on acute respiratory infections.
Other signal: “Syndromic indicators related to bronchiolitis were increasing in community medicine as well as in hospitals”Moreover “remaining at levels lower than those observed in the three years preceding the same period”he noted.
Of the 1,552 children under 2 years of age visited in the emergency room for bronchiolitis between October 21 and 27, 497 were hospitalized, almost all children under 1 year of age. Overseas, the epidemic has spread, knowing that Guyana has been affected by bronchiolitis since the end of July.
Two preventative treatments
Every year, during autumn and winter, bronchiolitis affects many French children, most often following an infection with respiratory syncytial virus (RSV), which can also threaten the elderly.
This season is characterized by the administration of two preventive treatments, Beyfortus, from AstraZeneca and Sanofi – an antibody administered directly to newborns -, and Abrysvo, from Pfizer – a vaccine administered before birth to pregnant women.
Beyfortus had already been the subject of an immunization campaign last year and studies agree that it limited the hospitalization of children in France and the few other countries where it was tested.
French Public Health also took stock of the evolution of the Covid-19 epidemic and seasonal flu, against which a combined vaccination campaign began in mid-October for people at risk, such as the elderly.
As for the flu, the cases detected in metropolitan France have remained until now “sporadic”while Réunion has been hit by an epidemic since the end of September. The reflux of the coronavirus continued, perceptible in community medicine, in hospitals, but also in wastewater.
“In addition to vaccinations and preventive treatments, the adoption of barrier actions to protect oneself from all winter diseases remains essential: washing hands, regularly ventilating rooms, wearing a mask in case of symptoms, in busy places and in the presence of people. vulnerable people”recalled Public Health France.
#Beginning #bronchiolitis #epidemic #metropolitan #France #IledeFrance #affected
Interview: The Annual Epidemic of Bronchiolitis Begins
Time.news Editor: Welcome to Time.news. Today we have the pleasure of speaking with Dr. Claire Dupont, a pediatric infectious disease specialist, to discuss the recent onset of the bronchiolitis epidemic in France. Thank you for joining us, Dr. Dupont.
Dr. Claire Dupont: Thank you for having me. It’s a critical time, and I’m glad to share insights on this significant health issue.
Editor: The annual epidemic of bronchiolitis has started, and Public Health France has reported shifts in various regions. Can you explain the seriousness of bronchiolitis, especially for children?
Dr. Dupont: Absolutely. Bronchiolitis primarily affects children under two, especially those under one year. It’s caused most often by the respiratory syncytial virus (RSV), which leads to inflammation of the small airways in the lungs. In severe cases, it can result in hospitalization, as we’ve seen with nearly a third of the children visiting emergency rooms last week requiring admission.
Editor: That does sound alarming. It’s noted that the syndromic indicators related to bronchiolitis are on the rise but still below the levels of the past few years. What could this imply?
Dr. Dupont: It suggests a shifting pattern; we are witnessing a resurgence, but thankfully, not as severe as previous years. This could be attributed to various factors, including previous public health measures related to COVID-19 or vaccination coverage. However, we must remain vigilant, as any rise in incidence can quickly translate into increased hospitalizations, particularly in vulnerable populations.
Editor: Speaking of prevention, there seems to be a focus on two new preventive treatments this season—Beyfortus and Abrysvo. Can you tell us a bit about them?
Dr. Dupont: Yes, these treatments are significant advancements. Beyfortus is an antibody treatment given directly to newborns, and evidence suggests it effectively limits hospitalizations. On the other hand, Abrysvo is a vaccine meant for pregnant women, passing on some immunity to the newborn. Implementing both could drastically change the way we handle bronchiolitis this season.
Editor: That’s fascinating. And what about the ongoing concerns regarding COVID-19 and seasonal flu, which you’ve mentioned in conjunction with bronchiolitis?
Dr. Dupont: It’s a complex situation. We’re in a period where multiple respiratory diseases are circulating simultaneously. Public Health France has initiated a combined vaccination campaign for high-risk groups, including the elderly, to prevent further complications. Ensuring vaccination can help mitigate the impact of these infectious diseases.
Editor: Considering your expertise, what do you recommend for parents to protect their children from bronchiolitis, especially during this critical time?
Dr. Dupont: Parents should prioritize vaccination where applicable and be vigilant about hand hygiene and avoiding close contact with sick individuals. If a child shows signs of respiratory distress, such as rapid breathing or wheezing, seeking prompt medical attention is essential. Awareness and education will play key roles in protecting our children this season.
Editor: Thank you, Dr. Dupont. Your insights are invaluable as we navigate this annual epidemic. This information will undoubtedly be helpful for many parents.
Dr. Dupont: Thank you for discussing this important topic. Together, we can improve awareness and outcomes for our children.
Editor: Thank you, and we look forward to more discussions in the future. Stay safe and healthy!